Phase Ib/IIa Dose Escalation and Expansion Study of [²¹²Pb]Pb-ADVC001 in Metastatic Prostate Cancer (TheraPb - Phase I/II Study).

NCT05720130 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
Metastatic Hormone Sensitive Prostate Cancer

Interventions

DRUG: [²¹²Pb]Pb-ADVC001 (Phase 1b)
DRUG: [²¹²Pb]Pb-ADVC001 (Phase 2a)

Sponsor

AdvanCell Pty Limited